No one loves harder than a mother, and the pain a mother feels when a child suffers one cannot even imagine. So when a mother loses a child, the hurt can do a lot of things. For some mothers, it pushes them to action, and that is exactly what happens to a grieving mom in Ohio who recently launched a battle against drug overdoses with a roadside billboard after the loss of her son.
Following the overdose death of her son, Lenora Lada paid to put up a billboard in the Marietta, Ohio to raise awareness about the Good Samaritan laws. She takes this action in hopes that other mothers may not have to grieve as she does.
Trey’s Life Mattered
The sign Lada bought shows a picture of her son, Trey Moats, and reads,
“His Life Mattered: No Excuse For Not Calling 911 or taking someone to a hospital,”
Trey’s mother had known about his struggles with addiction but had felt helpless as her 26-year-old child was unwilling to get the help he needed.
Then one day at 3:26 in the morning, she got a call from her son’s friends. Trey had been in a car with these friends when his lips turned blue as he overdosed, so they had driven him to another friend’s house to ask a mother there to perform CPR. But because they were too afraid to call 911, they called Trey’s mother instead and told her to come and get him. Lenora Lada states that by the time she arrived, her son was on the ground already gurgling.
By the time Lada arrived at her son’s side, it had already been 20-25 minutes. When she asked if someone had called 911, she was told by the other mother,
“No, I don’t want the squad and the sheriffs coming to my house again.”
Lada demanded that the daughter call 911, but Moats ultimately died at the hospital of multiple organ failures due to cardiac arrest and polysubstance abuse. Ever since that tragic and heartbreaking moment, Lenora Lada is determined to make sure people know that her son’s life mattered, as do the lives of other victims of overdose. The billboard also states:
“3/10 Mile could have saved Trey’s life.”
Lada believes a call to emergency responders could have saved her son. The sheriff’s report, however, states it is unclear if her son would have survived even if he was taken to the hospital. Local news reports that one coroner said Trey would have been brain dead, but another coroner did not seem so sure.
One thing is for sure though, Trey’s life did matter. And whether or not it was certain to make a difference, something more should have been done to try and save this young man’s life. That is why now Lada is also focused on raising awareness for Good Samaritan laws in Ohio.
We would like to offer you the FREE GIFT of a checklist to help decipher if you are helping or hurting a loved one who is struggling with addiction.
Click for FREE GIFT
Good Samaritan Awareness
According to the Good Samaritan law:
- Authorities cannot prosecute anyone who calls 911 to report an overdose
- Protects the person overdosing from prosecution
- Immunity is only good two times
- The law is not applicable to people on parole
Ohio’s Good Samaritan laws also require a survivor of an overdose to obtain a drug treatment referral within 30 days in order to avoid charges. This measure is in place with hopes to show more people who do suffer from addiction there are opportunities to seek help.
The intention of Good Samaritan laws is to reduce the hesitation to get help from bystanders who witness an overdose. These laws vary from jurisdiction to jurisdiction, with different interactions with other legal principals. But in essence, they are meant to prevent unnecessary overdose deaths by trying to take the fear of punishment out of the situation.
Lada also believes she would like part of the law to be changed, stating,
“I am asking for people to be accountable for not getting them help,”
What exactly that would look like is unclear, but for a mom who lost her son, it is an understandable sentiment. In many cases, there have been voices of support for charging drug dealers who sell to overdose victims with murder. So if this were to happen, what kind of punishment should someone face for not reporting an overdose?
Good Samaritan laws exist to help prevent deaths due to drug use, and there should be more of an effort to encourage people to report overdoses. Far too many sons and daughters are lost every day to drug overdoses. We should be taking every action we can to avoid more of the same. To defeat drug-related death requires prevention, education, and effective addiction treatment. If you or someone you love is struggling, do not hesitate. Please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Overprescribing of powerful prescription medications is just one part of how the current American opioid crisis came to be. While incredibly dangerous synthetic drugs like fentanyl came pouring in from across the globe, the pharmaceutical industry right in our own backyard thrived off of the devastation it was helping create. And as more people became aware of how prescription drugs were contributing to one of the worst drug epidemics in the country’s history, Big Pharma has come under fire for a number of things over the years. To name a few, we’ve seen arguments against drug companies for:
With recent reports, such as the explosive piece of 60 Minutes last month, we have also been exposed to the corruption, greed and a disregard for the well-being of the consumer.
The Big Pharma propaganda machine has paid out countless dollars for criminal and civil settlements over the years. Now even state officials are resorting to lawsuits against drug manufacturers in the fight against the ongoing opioid crisis.
So how did all this happen? How deep does the Big Pharma propaganda go? Some of this you might already know, but some of it might actually surprise you.
In case you didn’t know, the pharmaceuticals and health products industry spends the most money on lobbying politicians. And not even by a little.
Big Pharma and Health Products spent $3,714,580,815
That means that Big Pharma spends:
- $1,134,783,913 more than 2nd place- Insurance Companies
- $1,717,237,691 more than Oil/Gas Companies
The pharmaceutical industry, including dealers of medical products and nutritional/dietary supplements, is consistently a top contributor more to federal campaigns than any other industry.
In essence, drug companies spend big money on politics.
Whether we can always see it or not, this kind of financial incentive is more than likely playing into our current work on policy. For example, moves to pass legislation earlier this year were called into question by one source who pointed out 13 senators who were trying to push through a bill that would benefit the health insurance and pharmaceutical companies were receiving hundreds of thousands of dollars in contributions from these companies between 2010 and 2016, including:
- Utah Republican Senator Orrin Hatch led the way with more than $471,000
- Kentucky Republican Senator Mitch McConnell with over $433,00 in donations
FUN FACT- Many lobbyists working on behalf of Big Pharma companies have previously held government jobs.
Truthfully, drug companies spend several years before a drug even makes it to the market on planning a strategy for selling it to you. Part of that strategy is proving drugs have value for treatment. However, according to some industry insiders, a lot of the time there is not enough comprehensive data to prove that value.
What you might also find surprising is that some of the earliest information drug companies have published about their products aren’t actually from credible sources. Ad agencies will hire writers to produce articles on behalf of the drug maker highlighting benefits of a drug. But the data is often cherry-picked and incomplete.
These articles are then sold to the public as ‘scientific’ because they are printed and published by some of the biggest scientific and medical publications, such as the New England Journal of Medicine. Those articles are then picked up by television and other news sources.
So essentially, drug companies often team up with marketing companies to fool not just doctors, but the public into thinking their product provides something that has yet to be proven. Big Pharma propaganda corrupts the research into their drugs and makes people believe their products are safer and more effective than they are.
For more important information on the dangers of prescription drugs, download our FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”
DOWNLOAD FREE E-BOOK
Big Pharma’s Billions in Ads
It isn’t just behind the scenes that Big Pharma propaganda takes place. Drug makers spend around $21 billion a year just to pedal products through advertising. One big problem for Americans is that many of their promotional techniques have been called out for being false advertising or misleading, to say the least.
- 2015, the industry spent a record-breaking $5.4 billion of direct-to-consumer ads alone.
- The same year, Americans spent over $450 billion on prescription drugs.
Some sources indicate there are about 80 drug advertisements per hour. While drug companies want people to think it is raising awareness, it is most definitely a commercial to sell you something.
Many pharma companies even have deep financial ties to medical communication companies (MCC) like WebMD or Medscape. This is just one more way they can influence physicians and consumers without people realizing the drug makers are funding the information.
Doctors Recruiting Doctors
But the drug makers don’t stop with recruiting politicians to support them. They also utilize doctors to help them push their products. The main target audience in most of the campaigns pushed by Big Pharma propaganda is not necessarily the consumer as much as it is the person who writes the prescriptions.
Drug companies giving kickbacks to doctors is nothing new.
So drugmakers create an advisory board, where some of the most successful and well-respected doctors are put on the payroll with huge payoffs to help drug companies design a marketing campaign that will help promote the drugs to other doctors. Once these doctors have helped highlight the best ways to convince other physicians these drugs work, they themselves validate the drug in a way that encourages other doctors to prescribe the drug.
Drugs to Treat Drugs
A while back there was an ad that ran during the Superbowl that caught the attention of a lot of people. It was an ad selling an anti-constipation drug for those so dependent on prescription opioids that they were suffering from constipation as a side effect.
This is another huge problem with how drugs are marketed to us… in tandem.
Instead of suggesting an alternative treatment, drug companies want to give you more drugs to combat the effects of other drugs. Doctors will often prescribe a second medication for no other purpose than to treat the effects of the first medication. Big Pharma propaganda can literally sell you the illness and the medicine in the same marketing campaign. A 2012 study published in the journal Annals of Family Medicine describes this as “prescribing cascade”.The study indicates that the practice of using drugs to treat problems with other drugs is a key component to the heavy reliance on pharmaceuticals in healthcare.
Another devastating way this has taken place is when doctors prescribe powerfully and potentially habit-forming narcotic medications to combat illicit drug use and substance use disorder. Heroin addicts are being treated with other strong narcotics, which can actually have their own withdrawal symptoms and side effects. They even highjacked the opioid overdose antidote and several makers gouged the prices to offensive new heights during the rise of the opioid epidemic.
Drug Companies Abuse of Americans
Now let us be fair; modern medicine does provide us with some life-saving resources that can be paramount to the health and wellness of our population. Thanks to great strides in medicine doctors are able to treat some conditions or illnesses that were once thought of as a death sentence. Today, we have some of the greatest opportunities to receive quality care with innovative and well-researched treatments.
However, the fact remains that drug companies have been caught red-handed more than a few times misrepresenting their products, hiding the side-effects, falsely advertising their benefits and even recently some huge names in pharmaceuticals have been accused of bribery and racketeering to sell potent and extremely dangerous drugs.
So, what can be done?
- We can take a closer look at how Big Pharma propaganda influences or elected representatives and their decisions on policy.
- We can pay attention to how the information provided by pharmaceutical companies or marketers is not always as reliable as it may seem.
- Look into excessive advertising for potent drugs
- Do more to combat drug makers from paying doctors to promote their drugs to other doctors.
- Pursue other forms of treatment that don’t require expensive and powerful drugs.
When it comes to drug abuse, maybe we shouldn’t let the drug companies continue to make massive profits from a problem they have a large hand in creating. There needs to be more commitment to finding alternative treatments that don’t rely so heavily on drugs in order to help people get healthy.
Holistic drug addiction treatment is a unique and effective way of helping people struggling with substance use disorder. The fact that powerful drugs help cause addiction, let us not forget the value of offering healing options that don’t require more drugs. Building a strong foundation with personalized therapy and innovative treatment opportunities helps thousands of people all over the nation overcome addiction. Palm Partners Recovery Center is committed to providing quality care for those dealing with drug abuse, whether it is illicit drugs or prescription drug dependence. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
Author: Justin Mckibben
You may remember back in early 2016 the pharmacy organization Walgreens announced two programs to address key issues in the opioid crisis.
- Safe medical disposal kiosks for unused prescription drugs
- Narcan expansion programs
By the end of 2016, Walgreens had expanded access to the opioid overdose antidote without the requirement of a prescription to 33 states and the District of Columbia. The Narcan opioid overdose antidote, also known by the generic name Naloxone, is a nasal spray that is utilized all over the country as a means to revive someone experiencing an opioid overdose.
Now, this life-saving compound is becoming even more accessible, as Walgreens is announcing the Narcan opioid overdose antidote will now be available at all of its over 8,000 pharmacy locations!
Pharmacies Stepping Up to the State of Emergency
This new move to combat the opioid epidemic comes at a crucial time. The epidemic continues to claim lives every day, with recovery advocates and government officials rallying for more resources to fight the problem.
Today, Thursday, October 26, 2017, the nation is expecting President Donald Trump to officially declare the opioid crisis a public health emergency at a scheduled White House event.
According to Rick Gates, Vice President of Walgreens,
“By stocking Narcan in all our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed.”
The company offers Narcan opioid overdose antidote without a prescription in 45 states and is willing to work with the remaining states to make to include them.
Of course, the fight for more availability of Narcan and Naloxone has been going on for some time. However, it seems as the country is calling for more sweeping action from government officials; pharmacies are taking it as a call to action themselves. Rick Gates went on to say,
“As a pharmacy, we are committed to making Narcan more accessible in the communities we serve.”
Walgreens also says it will inform customers about the Narcan opioid overdose antidote if they receive drugs with more than 50 morphine milligram equivalents (MME). This is actually a recommendation from the CDC.
It isn’t just Walgreens either. CVS pharmacy has expanded access to Narcan and other products that contain naloxone. CVS reportedly has been offering prescription-free naloxone in up to 43 states as of last month. CVS pharmacies have said that its locations “in most communities have naloxone on hand and can dispense it the same day or ordered for the next business day.”
Big Pharma’s Role
Big Pharma wholesaler AmerisourceBergen is also helping in these efforts. AmerisourceBergen is now distributing Narcan demo devices at no cost to Walgreens pharmacists. These demo devices will help with instructing patients on how to administer the medication safely and effectively.
Robert Mauch, Executive Vice President & Group President, Pharmaceutical Distribution & Strategic Global Sourcing for AmerisourceBergen, states,
“At AmerisourceBergen, we strive to provide our customers the highest quality care and support so they can ultimately enhance the lives of patients in their communities,”
“We recognize the important role we play in addressing the opioid epidemic, and our collaboration with Walgreens is another key milestone to supply our customers with access to lifesaving initiatives and emergency medications that can help keep individuals safe across the country.”
Ironically, AmerisourceBergen just so happens to be one of the three largest drug distributors that were mentioned in the recent 60 Minutes interview with ex-DEA agent Joe Rannazzisi. In the segment that has since caused a major uproar, Rabbazzisi said companies including AmerisourceBergen controlled probably 85%- 90% of drugs that went “downstream” and ended up on the streets.
This might not be what Mauch meant by “recognize the important role we play”, but at least it seems like AmerisourceBergen is taking steps to become part of a solution.
Meanwhile, Adapt Pharma, the manufacturer of Narcan Nasal Spray, celebrates this action by Walgreens to expand naloxone and Narcan access. Seamus Mulligan, CEO at Adapt Pharma states,
“This action is an important milestone and we applaud Walgreens initiatives to improve access to Narcan Nasal Spray in communities across the U.S.,”
“This effort, combined with the opportunity for patients and caregivers to obtain Narcan Nasal Spray without an individual prescription in 45 states, is critical in combating this crisis.”
America is working hard to find the right path on the road to recovery from the devastating opioid crisis. It is crucial that we make every possible resource available to help save lives. With opioid overdose killing an estimated 91 people every day, the need for this life-saving medication could not be more evident.
Beyond reversing the effects of an overdose, there is more we need to do. While having access to Narcan and naloxone can help tremendously, we also need to promote recovery and addiction treatment resources. Preservation of life is important, but giving people the help they need to live a happier and healthier life should also be a priority in the fight to overcome the opioid crisis. Palm Partners Recovery Center believes in actively providing the best in innovative and holistic treatment opportunities, to help transform lives. If you or someone you love is struggling with substance abuse or addiction, we want to help. Please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
The Global Commission on Drug Policy (GCDP) is an international institution of global leaders and intellectuals working to help study and inform initiatives on addressing drug use all around the world. This think tank offers recommendations concerning drug use and its consequences for societies across the globe.
The GCDP consists of members from various nations, including but not limited to:
- The United States of America
- The United Kingdom
Former U.S. President Jimmy Carter wrote an op-ed in The New York Times explicitly endorsing the recommendations of the Global Commission on Drug Policy, and the group has released various reports over the years focusing on the efforts to curb the spread of drug abuse.
Recently the GCDP released a position report on the North American opioid epidemic. In this report, the commission issues recommendations that appear to endorse the expansion of harm reduction techniques to battle the ongoing crisis.
The Turning Point for America
According to the GCDP’s new report, North America is at a turning point in the way that drug addiction is viewed. This is not too much of a surprise, considering now more than ever there has been a push for a more compassionate perspective on drug use and addiction. America now finds itself in a unique position where the stigma that has so long been attached to addiction is starting to be abandoned, and more progressive action is being taken.
Now the Global Commission on Drug Policy believes national policymakers should take advantage of this unique opportunity to reduce opioid-related deaths through harm reduction. In the report the authors state:
“While in recent years media and politicians have been more open to viewing addiction as a public health problem, leadership is needed to turn this into an urgent and commensurate response to the crisis,”
One way that the Global Commission on Drug Policy ideals clashes with that of the Trump administration, currently steering drug policy in America is that the GCDP does not endorse the old policies of the War on Drugs.
GCDP vs War on Drugs
Back in June of 2011, the GCDP stated:
“The global war on drugs has failed, with devastating consequences for individuals and societies around the world.”
Again, this recent report echoes that sentiment, saying that attempting to cut off the opioid supply is not the answer. The new report notes how this approach has been tried before, as the first reactions to the opioid epidemic were to limit prescriptions and to introduce pills that were harder to manipulate.
The report goes on to note that this response drove people to use cheaper and often much more potent street drugs instead of prescription pills. Fentanyl is one of the worst synthetic opioids to contribute to the outbreak of overdoses and deaths across the country.
The Global Commission on Drug Policy says cutting off the supply of opioids into the country cannot be effectively executed until after supportive measures are put in place. This means supporting not only both people battling addiction but also people with chronic pain. The report insists:
“The aim is to achieve the right balance in regulation to provide effective and adequate pain care, while minimizing opportunities for misuse of these medications.”
To reduce the harmful impacts of opioids, the commission calling for the acceptance and implementation of harm reduction strategies.
The Global Commission on Drug Policy Suggests Harm Reduction
So if they are saying that the War on Drugs did not work, and neither will bulking up borders, then what will?
Well, according to the GCDP, harm reduction is the right move. The new report calls on American lawmakers to promote programs like:
Naloxone Distribution and Training
As the opioid overdose antidote, Naloxone is an invaluable tool to have in the fight against the opioid epidemic in America, but the price for the drug continued to skyrocket as the epidemic got worse. Making it more available could give access to and train people with life-saving medication to thousands or even millions more.
Safe locations where IV drug users can trade old, contaminated needles for new, sterile needles to help prevent the spread of blood-borne illness like HIV.
Facilities where drug users can go to use their drugs with sterile equipment safely, reducing the number of overdose deaths by providing a place free of punishment for them to use with medical emergency resources on site.
These kinds of programs would allow for users to check their drugs for the presence of any unknown substances it may have been diluted with. For example, most fentanyl users do not know they are using fentanyl.
Decriminalizing Drugs in America
In another aspect of the report, GCDP also makes a much more revolutionary and more radical suggestion that many may consider qualifying as harm reduction: decriminalization.
The report states:
“The Global Commission on Drug Policy also calls for the elimination of illicit drug markets by carefully regulating different drugs according to their potential harms. The most effective way to reduce the extensive harms of the global drug prohibition regime and advance the goals of public health and safety is to get drugs under control through responsible legal regulation.”
With this philosophy in mind, the GCDP made two more drastic recommendations:
- End the criminalization and incarceration of people who use drugs nation-wide in Canada and the United States.
- Allow and promote pilot projects for the responsible legal regulation of currently illicit drugs including opioids.
The idea is that by decriminalizing drugs, they can bypass criminal organizations and ultimately replace the current black market.
“Do not pursue such offenses so that people in need of health and social services can access them freely, easily, and without fear of legal coercion,”
We have begun to see a watered-down variation of this kind of strategy with many Police Assisted Addiction and Recovery Initiative (PAARI) programs, where law enforcement is helping addicts get into treatment instead of arresting them when they ask for help.
Better Treatment Research
The report insists that more research is necessary in a few critical areas in order the effectively address the opioid crisis and the overall drug problem in America.
One of the key points of research the GCDP proposes is for finding the most effective treatments for addiction, specifically to prescription opioids. In addition, the report shows support for medication-assisted treatment (MAT) and opioid substitution therapy (OST) as a means to preserve life to assist in the recovery process. While these programs are met with some of the same contentions as safe injection sites or decriminalization, the commission seems adamant about using harm reduction to keep people alive long enough to get better.
Michel Kazatchkine, a doctor and commission member, said in a recent interview:
“Repression is harmful. Wherever repressive policies are in place, people will not be in the best condition to access services.”
While he and other commission members are in no way naïve to the fact there is no way decriminalization will happen at the federal level soon in the U.S., they remain hopeful that states or cities will make decisions which don’t require federal approval, or for which they are willing to enter to fight with the federal process.
Overall, the hope of the GCDP is that these suggestions, coming from a group of world leaders fully invested in understanding the issue, will convince American and Canadian lawmakers to take a progressive approach to the crisis.
What could some of these changes mean for those trying to recover from opioid abuse? How could some of these ideas change the way addiction treatment operates within America?
One thing is for certain, in fighting opioid addiction, whether as a society, as a family or as an individual, there needs to be compassion and action. It takes courage and it takes a degree of uncertainty. But with the right resources, there is hope for a greater future. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
The Center for Disease Control and Prevention (CDC) announced on September 5th it would be allocating more than $28.6 million in funding to assist dozens of states, not to mention the District of Columbia, with overcoming the issues they face concerning opioid abuse, addiction, overdose and opioid related death. Many states are still struggling to make headway in the uphill battle. Thanks to the CDC fighting opioids with such a large contribution people in these areas have a better chance of gaining access to crucial resources.
It All Adds Up
The Omnibus Appropriations Bill in 2017 added funding for fighting the opioid epidemic with a $103 million dollar contribution. Combined with this new money from the CDC there will be even more support for things such as:
Addiction prevention programs
Drug monitoring programs
Improved toxicology testing for medical examiners/coroners
This isn’t the first time this year the CDC has dropped a big sum into the opioid outbreak.
Just a few months back in July the CDC fighting opioids led to a $12 million pledge to state overdose prevention efforts. This contribution was made as part of the plan from the Department of Health and Human Services’ (DHHS) in response to the nationwide opioid epidemic.
Who Gets the Money?
So which states are receiving funding through this latest pledge, and why? This money is being distributed out to various states that participate in the CDC’s Overdose Prevention in States Program (OPiS). The OPiS program includes 3 unique programs designed for prevention efforts:
Prescription Drug Overdose: Prevention for States (PfS)
This program will provide $19.3 million in funding to 27 states to expand various of their prevention programs, which also use community outreach.
Data-Driven Prevention Initiative (DDPI)
$4.6 million will go through DDPI to 12 states and Washington, D.C. for similar programs. Other states getting funds through the DDPI include:
Enhanced State Opioid Overdose Surveillance (ESOOS)
Across the country around $4.7 million will go to medical examiners and coroners in 32 states and D.C. to track and prevent overdoses. The top 5 states on the list of highest rates of overdose death will receive funding, which includes:
-as well as-
How is CDC Fighting Opioids?
Not only is the OPiS program a big portion of the plan to fight opioids from the DHHS, but there are 4 other key components to these efforts.
Naloxone expansion programs
Improving public health data related to opioid crisis
Advancing practices for pain management
Greater research and support on addiction and pain
DHHS Secretary Tom Price states that the funding expansion was made possible through legislation signed by the Trump administration earlier this year. He insists it is an important part of committing help to states combating opioid addiction and overdose.
Many are hopeful that this will be the beginning of a trend for allocating funds toward more resources for CDC fighting opioids and the damage they cause across America. Advocates are still hopeful to receive more support, but for now there is at least some hope that something is being done. As far as each individual, recovery begins with taking advantage of any opportunity in front of you to do better. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.
CALL NOW 1-800-951-6135